Publication Information

{'id': 'https://openalex.org/W1947312590', 'doi': None, 'title': 'Both Etanercept and Infliximab Can Elevate Tumor Necrosis Factor (TNF)-α and Be the Cause of Treatment Related New Onset Disease: the Need to Measure Circulating TNF-α', 'display_name': 'Both Etanercept and Infliximab Can Elevate Tumor Necrosis Factor (TNF)-α and Be the Cause of Treatment Related New Onset Disease: the Need to Measure Circulating TNF-α', 'publication_year': 2008, 'publication_date': '2008-08-01', 'ids': {'openalex': 'https://openalex.org/W1947312590', 'mag': '1947312590', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/18671327'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://www.jrheum.org/content/jrheum/35/8/1679.1.full.pdf', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S50602745', 'display_name': 'The Journal of Rheumatology', 'issn_l': '0315-162X', 'issn': ['0315-162X', '1499-2752'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320417', 'host_organization_name': 'The Journal of Rheumatology Publishing Company Limited', 'host_organization_lineage': ['https://openalex.org/P4310320417'], 'host_organization_lineage_names': ['The Journal of Rheumatology Publishing Company Limited'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5016608605', 'display_name': 'Richard E. Kast', 'orcid': 'https://orcid.org/0000-0002-7876-0400'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Richard E. Kast', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5037266328', 'display_name': 'Eric Lewin Altschuler', 'orcid': 'https://orcid.org/0000-0002-3575-6954'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Eric L. Altschuler', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': False, 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.355469, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 74, 'max': 76}, 'biblio': {'volume': '35', 'issue': '8', 'first_page': '1679', 'last_page': '1680'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9947, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9947, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 0.9942, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10134', 'display_name': 'Inflammatory Bowel Disease', 'score': 0.9935, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/contest', 'display_name': 'CONTEST', 'score': 0.47992998}], 'concepts': [{'id': 'https://openalex.org/C2777226972', 'wikidata': 'https://www.wikidata.org/wiki/Q415343', 'display_name': 'Etanercept', 'level': 3, 'score': 0.9540419}, {'id': 'https://openalex.org/C2777138892', 'wikidata': 'https://www.wikidata.org/wiki/Q415264', 'display_name': 'Infliximab', 'level': 3, 'score': 0.9275925}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9216988}, {'id': 'https://openalex.org/C2777402515', 'wikidata': 'https://www.wikidata.org/wiki/Q52849', 'display_name': 'Ankylosing spondylitis', 'level': 2, 'score': 0.7875154}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.770198}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.5357866}, {'id': 'https://openalex.org/C2777582232', 'wikidata': 'https://www.wikidata.org/wiki/Q5013414', 'display_name': 'CONTEST', 'level': 2, 'score': 0.47992998}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4096753}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.39694014}, {'id': 'https://openalex.org/C17744445', 'wikidata': 'https://www.wikidata.org/wiki/Q36442', 'display_name': 'Political science', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C199539241', 'wikidata': 'https://www.wikidata.org/wiki/Q7748', 'display_name': 'Law', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': True}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054316', 'descriptor_name': 'Biomarkers, Pharmacological', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054316', 'descriptor_name': 'Biomarkers, Pharmacological', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D003424', 'descriptor_name': 'Crohn Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003424', 'descriptor_name': 'Crohn Disease', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D000068800', 'descriptor_name': 'Etanercept', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069285', 'descriptor_name': 'Infliximab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018124', 'descriptor_name': 'Receptors, Tumor Necrosis Factor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://www.jrheum.org/content/jrheum/35/8/1679.1.full.pdf', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S50602745', 'display_name': 'The Journal of Rheumatology', 'issn_l': '0315-162X', 'issn': ['0315-162X', '1499-2752'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320417', 'host_organization_name': 'The Journal of Rheumatology Publishing Company Limited', 'host_organization_lineage': ['https://openalex.org/P4310320417'], 'host_organization_lineage_names': ['The Journal of Rheumatology Publishing Company Limited'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/18671327', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.82, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 28, 'referenced_works': ['https://openalex.org/W112367184', 'https://openalex.org/W1773552353', 'https://openalex.org/W1813981428', 'https://openalex.org/W1833207062', 'https://openalex.org/W1852410481', 'https://openalex.org/W1970551142', 'https://openalex.org/W1985196248', 'https://openalex.org/W1995588846', 'https://openalex.org/W2003652884', 'https://openalex.org/W2008131591', 'https://openalex.org/W2020188309', 'https://openalex.org/W2025755851', 'https://openalex.org/W2039778748', 'https://openalex.org/W2051560783', 'https://openalex.org/W2054138790', 'https://openalex.org/W2054515559', 'https://openalex.org/W2055552847', 'https://openalex.org/W2055865775', 'https://openalex.org/W2072882391', 'https://openalex.org/W2077904842', 'https://openalex.org/W2095897932', 'https://openalex.org/W2097496123', 'https://openalex.org/W2105281471', 'https://openalex.org/W2107268345', 'https://openalex.org/W2107744742', 'https://openalex.org/W2141138459', 'https://openalex.org/W2151711365', 'https://openalex.org/W2171543193'], 'related_works': ['https://openalex.org/W2894748384', 'https://openalex.org/W2582981810', 'https://openalex.org/W2417817637', 'https://openalex.org/W2370622528', 'https://openalex.org/W2325764353', 'https://openalex.org/W2297514571', 'https://openalex.org/W2252829258', 'https://openalex.org/W2164777498', 'https://openalex.org/W2160832116', 'https://openalex.org/W2113218931', 'https://openalex.org/W2105974002', 'https://openalex.org/W2095767221', 'https://openalex.org/W2093214037', 'https://openalex.org/W2082432600', 'https://openalex.org/W2066715803', 'https://openalex.org/W2052326266', 'https://openalex.org/W2049161311', 'https://openalex.org/W2044504348', 'https://openalex.org/W1966524332', 'https://openalex.org/W1823274426'], 'abstract_inverted_index': {'To': [0], 'the': [1, 6, 31, 59, 72], 'Editor:\n\nWe': [2], 'read': [3], 'with': [4, 26, 51], 'interest': [5], 'documentation': [7], 'by': [8, 48], 'Song,': [9], 'et': [10], 'al': [11], 'of': [12, 23, 38], 'new': [13], 'onset': [14], 'Crohn’s': [15], 'disease': [16], '(CD)': [17], 'in': [18], 'a': [19, 35], 'patient': [20], 'after': [21], 'treatment': [22, 50], 'ankylosing': [24], 'spondylitis': [25], 'etanercept1.': [27], 'Their': [28], 'report': [29], 'is': [30], 'latest': [32], 'addition': [33], 'to': [34], 'long': [36], 'list': [37], 'tumor': [39], 'necrosis': [40], 'factor': [41], '(TNF)-α': [42], 'mediated': [43], 'disease,': [44], 'generated': [45], 'or': [46, 53], 'worsened': [47], 'anti-TNF-α': [49], 'etanercept': [52, 95], 'infliximab.': [54], 'We': [55, 87], 'do': [56], 'not': [57], 'contest': [58], 'several': [60], 'dozen': [61], 'carefully': [62], 'thought': [63], 'out': [64], 'and': [65, 96], 'well': [66], 'documented': [67], 'risk-benefit': [68], 'assessments': [69], 'published': [70], 'over': [71], 'last': [73], '10': [74], 'years': [75], 'that': [76], 'show': [77], 'clear': [78], 'benefit': [79], 'from': [80], 'both': [81], 'agents': [82], 'for': [83], 'their': [84], 'respective': [85], 'indications.': [86], 'simply': [88], 'add': [89], 'here': [90], '2': [91], 'reminders:': [92], '(1)': [93], 'Both': [94], 'infliximab': [97], 'have…': [98]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1947312590', 'counts_by_year': [{'year': 2016, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}], 'updated_date': '2024-12-16T19:17:27.502712', 'created_date': '2016-06-24'}